Conéctate
Conéctate
O Conectarse con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Regístrate
O Conectarse con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Inicio
  2. Acciones
  3. India
  4. Bombay Stock Exchange
  5. Jubilant Pharmova Limited
  6. Noticias
  7. Otros idiomas
    530019   INE700A01033

JUBILANT PHARMOVA LIMITED

(530019)
  Reporte
Precio de cierre Bombay Stock Exchange  -  06/10/2022
343.00 INR   +1.84%
14/09Jubilant Pharmova Limited nombra a Jaidev Rajpal director de su negocio de genéricos, a partir del 11 de octubre de 2022
CI
03/09Jubilant Pharmova Limited recomienda un dividendo para el año que termina el 31 de marzo de 2022, pagadero el 24 de octubre de 2022 o antes
CI
19/08Los índices indios terminan en negativo; IndusInd Bank cae un 4%.
MT
ResumenCotizacionesGráficosNoticiasRatingsAgendaEmpresaFinanzasConsensoRevisionesFondos 
ResumenTodasOtros idiomasComunicadosPubls. oficialesNoticias del sector
Noticias en otros idiomas sobre JUBILANT PHARMOVA LIMITED
14/09Jubilant Pharmova Limited Appoints Jaidev Rajpal as Head of Its Generics Business, Effe..
03/09Jubilant Pharmova Limited Recommends Dividend for the Year Ended March 31, 2022, Payabl..
03/09Jubilant Pharmova : Annual Report 2021-22
03/09Jubilant Pharmova : Notice 2021-22
19/08Indian Indices End on Negative Note; IndusInd Bank Slides 4%
19/08Jubilant Pharmova Unit Redeems $200 Million of 6% Bonds Ahead of 2024 Maturity
03/08Jubilant Pharmova Arm Gets Six Observations from US FDA After Inspection of Roorkee, In..
02/08Transcript : Jubilant Pharmova Limited, Q1 2023 Earnings Call, Aug 02, 2022
02/08Jubilant Pharmova Limited Reports Earnings Results for the First Quarter Ended June 30,..
29/07Jubilant Pharmova Limited Recommends Final Dividend for the Year Ended March 31, 2022, ..
14/07US FDA Removes Three Tablets of Jubilant Pharmova Unit from Excepted Products List
14/07Jubilant Pharmova Arm Secures $400 Million Loan Facility
14/07Jubilant Pharmova : General updates
01/07Jubilant Pharmova Limited Approves Executive and Board Changes
01/07Jubilant Pharmova Arm to Expand Montreal, Canada Manufacturing Facility with $78 Millio..
30/05Jubilant Pharmova Signs $150 Million Deal to Expand Critical Vaccine Manufacturing Capa..
27/05Jubilant Pharmova Limited Reports Earnings Results for the Fourth Quarter Ended March 3..
27/05Jubilant Pharmova Limited Reports Earnings Results for the Full Year Ended March 31, 20..
27/05Transcript : Jubilant Pharmova Limited, Q4 2022 Earnings Call, May 27, 2022
27/05Jubilant Pharmova Limited Recommends Dividend for the Year Ended March 31, 2022, Payabl..
04/04Jubilant Pharmova to Acquire 25.21% Stake in Herbal Products Manufacturer
02/04Jubilant Pharmova Limited acquired 25.21% interest in SPV Laboratories Pvt Ltd. for INR..
17/03Jubilant Pharmova Unit Gets US FDA's Approval for Depression Drug
02/03Jubilant Pharmova : Investor Presentation February 2022
17/02Fitch Maintains BB Rating on Jubilant Pharmova Unit; Lowers Outlook to Negative
04/02Transcript : Jubilant Pharmova Limited, Q3 2022 Earnings Call, Feb 04, 2022
04/02Jubilant Pharmova Limited Reports Earnings Results for the Third Quarter and Nine Month..
2021Jubilant Pharma's Profit Slips in July-September
2021Transcript : Jubilant Pharmova Limited, Q2 2022 Earnings Call, Oct 22, 2021
2021Jubilant Pharmova Limited Reports Earnings Results for the Second Quarter and Six Month..
2021Jubilant Pharmova Limited Approves Declaration of Dividend for the Year Ended March 31,..
2021Jubilant Pharmova Limited Recommends Dividend for the Year Ended March 31, 2021, Payabl..
2021Jubilant Pharmova : Consolidated Profit Jumps in Fiscal Q1
2021Transcript : Jubilant Pharmova Limited, Q1 2022 Earnings Call, Jul 23, 2021
2021Jubilant Pharmova Limited Reports Earnings Results for the First Quarter Ended June 30,..
2021Jubilant Pharmova Announces That the US FDA Has Placed Roorkee Facility Under Import Al..
2021Transcript : Jubilant Pharmova Limited - Analyst/Investor Day
2021Jubilant Pharmova : Consolidated Profit Slides in Fiscal Q4
2021Jubilant Pharmova Limited Recommends Dividend for the Year Ended March 31, 2021, Payabl..
2021Jubilant Pharmova Limited Reports Earnings Results for the Fourth Quarter Ended March 3..
2021Jubilant Pharmova : Subsidiary to Invest $92 Million to Expand US Faci..
2021Jubilant Pharmova Limited to Invest $92 Million to Expand Sterile Injectable Manufactur..
2021Jubilant Pharmova : US Appellate Court Denies Bracco Diagnostics' Appe..
2021Jubilant Pharmova : Unit Develops Oral Formulation of COVID Drug Remde..
2021India bans Remdesivir exports as coronavirus rages on; rallies continue
2021Jubilant Pharmova Limited Announces Executive Appointments
2021Jubilant Pharmova Limited Appoints Arvind Chokhany as Group Chief Financial Officer
2021Jubilant Pharmova : Pharma Posts Higher Profit in October-December 202..
2021Jubilant Pharmova Limited Announces Directorate Changes
2021Transcript : Jubilant Life Sciences Limited, Q3 2021 Earnings Call, Feb 05, 2..
2021Jubilant Pharmova Limited Reports Earnings Results for the Third Quarter Ended December..
2021Jubilant Life Sciences Ltd. Announces Early Redemption of 4.875% Senior Notes Due 2021
2021Jubilant Pharmova : Gets New Name; Singapore Unit Names CFO
2021Jubilant Life Sciences Limited has Changed its Name to Jubilant Pharmova Limited
2021The Board of Jubilant Life Sciences Limited completed the spin-off of Life Science Ingr..
2020Market Chatter: Jubilant Life Sciences Eyes $500 Million for Pharma Busin..
2020Jubilant Pharmova : Life Sciences Issues $12 Million Commercial Papers
2020Jubilant Pharmova : Pharma Posts Fall in Fiscal Second Quarter Profit,..
2020Jubilant Pharmova : Life to Raise up to $14 Million from Nonconvertibl..
2020Jubilant Pharmova : Life's Singapore Unit Inks $25 Million Deal for Mi..
2020Jubilant Life Sciences Limited Issues Privately Placed Secured, Rated & Redeemable Non-..
2020Transcript : Jubilant Life Sciences Limited, Q2 2021 Earnings Call, Nov 04, 2..
2020Jubilant Life Sciences Limited Reports Earnings Results for the Second Quarter Ended Se..
2020Jubilant Life Sciences Limited Announces the Resignation of Alok Vaish as Chief Financi..
2020Jubilant Life Sciences Limited Reports Earnings Results for the First Quarter Ended Jun..
2020Zydus Cadila launches India's cheapest remdesivir version at $37 per vial
2020India's shortage of remdesivir is easing, says producer Cipla
2020Sun Pharma latest to sell COVID-19 drug favipiravir in India
2020Transcript : Jubilant Life Sciences Limited, Q4 2020 Earnings Call, May 29, 2..
2020Jubilant Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended Ma..
2020Gilead Sciences, Inc. Signs Licensing Agreements with Cipla Limited, Hetero Labs Limite..
2020Gilead ties up with generic drugmakers for COVID-19 drug supply
2020Gilead ties up with generic drugmakers for COVID-19 drug supply
2020Jubilant Life Sciences Ltd Grants Exclusive License to Lengo Therapeutics, Inc
2020Transcript : Jubilant Life Sciences Limited - Special Call
2020Jubilant Life Sciences Limited Declares Interim Dividend for the Financial Year 2019-20..
2020Jubilant Life Sciences Limited Declares Interim Dividend, Payable on or Before, March 2..
2020Jubilant Life Sciences Limited Reports Earnings Results for the Third Quarter Ended Dec..
2020Transcript : Jubilant Life Sciences Limited, Q3 2020 Earnings Call, Jan 31, 2..
2019Jubilant Life Sciences Limited Announces Early Redemption of Non-Convertible Debentures
2019Transcript : Jubilant Life Sciences Limited, Q2 2020 Earnings Call, Oct 25, 2..
2019Jubilant Life Sciences Limited Reports Earnings Results for the Second Quarter Ended Se..
2019Jubilant Life Sciences Limited Announces Management Changes
2019Jubilant Life Sciences Limited agreed to Spin-Off Life Science Ingredients business of ..
2019Jubilant Life Sciences : Shanti Raghavan & Dipesh Sutariya of EnAble India win the Social ..
2019Jubilant Life Sciences Limited Approves Dividend
2019Jubilant Life Sciences : Celebrating a decade of partnership ‘Social Entrepreneur of..
2019Jubilant Life Sciences : Announces Appointment of Dr. Syed Kazmi as President and CEO of i..
2019Jubilant Life Sciences Limited Proposes Dividend, Payable on or Before October 24, 2019
2019Jubilant Life Sciences Limited Reports Earnings Results for the First Quarter Ended Jun..
2019Transcript : Jubilant Life Sciences Limited, Q1 2020 Earnings Call, Jul 26, 2..
2019Jubilant To Evaluate Strategic Options for JLL Businesses
2019Jubilant Life Sciences Limited acquired 0.08% stake in Jubilant Biosys Limited from Shy..
2019Transcript : Jubilant Life Sciences Limited, Q4 2019 Earnings Call, May 17, 2..
2019Jubilant Life Sciences Limited Recommends Dividend for the Year Ended March 31, 2019, P..
2019Jubilant Life Sciences Limited Announces Audited Consolidated and Standalone Earnings R..
2019Transcript : Jubilant Life Sciences Limited, Q3 2019 Earnings Call, Feb 01, 2..
2019Jubilant Life Sciences Limited Announces Unaudited Standalone and Consolidated Earnings..
2018Jubilant Life Sciences Limited Announces Unaudited Consolidated Earnings Results for th..
2018Transcript : Jubilant Life Sciences Limited, Q2 2019 Earnings Call, Oct 22, 2..
Próximo evento sobre JUBILANT PHARMOVA LIMITED